Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Solid Tumors in Asians

NCT02703298 is registered in ClinicalTrials.gov with TaiRx, Inc. as lead sponsor.

NCT NCT02703298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02703298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Solid Tumors in Asians
Lead sponsor
TaiRx, Inc.
Phase
Phase 1
Overall status
Completed
Start date
March 25, 2016
Completion date
May 3, 2018
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, carcinoma